Early study checks how new drug DA-1229_01 behaves in the body
NCT ID NCT07342062
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial looked at how the drug DA-1229_01 is absorbed and processed in 36 healthy adults when taken with food. Participants received a single dose of the drug in two different forms to compare their safety and levels in the blood. The study is complete and focused on gathering basic information, not on treating any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- DA-1229_01 (a drug being tested for how the body processes it)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bumin hospital
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test